Our understanding of medial temporal lobe epilepsy has advanced in recent times following progress in histopathology, electrophysiology, and functional neuroimaging; however, our understanding is incomplete and requires further refinements in postoperative seizure outcomes. Medial temporal lobe epilepsy is likely to exist as part of a constellation of developmental brain abnormalities and environmental factors that together produce epilepsy. 1 We previously used 18 F-fluorodeoxyglucose-positron emission tomography (FDG-PET) and magnetoencephalography (MEG) to characterize interictal functional properties of the epileptogenic zone of the temporal lobe in patients with medial temporal lobe epilepsy. 2 We propose that the equivalent current dipole is distributed in varied ways with the disorder and uncoupling of glucose metabolism and perfusion in the temporal lobe; however, the clinical impact of FDG-PET and MEG on postoperative seizure outcome remains unresolved. Prediction of postoperative seizure outcome based on preoperative evaluation is not straightforward because of the diversity and complexity of medial temporal lobe epilepsy. [3] [4] [5] [6] [7] [8] [9] [10] [11] Careful preoperative analysis may enable us to formulate goals for surgical treatment. Objective: The objective of this retrospective study is to analyze whether preoperative functional imaging studies using FDG-PET and MEG enable prediction of postoperative seizure outcomes. Methods: Thirty-six patients with intractable temporal lobe epilepsy were studied. Asymmetry index of tCMRgluc (PET-AI) and the equivalent current dipole intensity of first response of SEF (SEF-AI) were determined preoperatively using 18 F-fluorodeoxyglucose-positron emission tomography (FDG-PET) and magnetoencephalography (MEG), respectively. Seizure outcomes were evaluated according to the classification proposed by the International League Against Epilepsy (ILAE) at least 24 months after resection of epileptic focuses. Twelve healthy volunteers were included in this study to determine the normal value. Results: Quantitative analysis revealed mean PET-AI in the patients was 5.4 AE 5.2% (significantly different from normal controls); mean SEF-AI was 25.2 AE 20.6% (not significantly different). PET-AI was positive (indicative of epileptic focus) in 29 of 36 patients (80.6%), while SEF-AI was positive in 17 of 36 patients (47.2%). Although no significant correlation between PET-AI and SEF-AI was noted (r = 0.43), concordant asymmetry in both PET-AI and SEF-AI was significantly associated with better seizure outcome than discordant or paradoxical asymmetry of both factors (p < 0.01).
Introduction
Our understanding of medial temporal lobe epilepsy has advanced in recent times following progress in histopathology, electrophysiology, and functional neuroimaging; however, our understanding is incomplete and requires further refinements in postoperative seizure outcomes. Medial temporal lobe epilepsy is likely to exist as part of a constellation of developmental brain abnormalities and environmental factors that together produce epilepsy. 1 We previously used 18 F-fluorodeoxyglucose-positron emission tomography (FDG-PET) and magnetoencephalography (MEG) to characterize interictal functional properties of the epileptogenic zone of the temporal lobe in patients with medial temporal lobe epilepsy. 2 We propose that the equivalent current dipole is distributed in varied ways with the disorder and uncoupling of glucose metabolism and perfusion in the temporal lobe; however, the clinical impact of FDG-PET and MEG on postoperative seizure outcome remains unresolved. Prediction of postoperative seizure outcome based on preoperative evaluation is not straightforward because of the diversity and complexity of medial temporal lobe epilepsy. [3] [4] [5] [6] [7] [8] [9] [10] [11] Careful preoperative analysis may enable us to formulate goals for surgical treatment. Seizure 18 (2009) [1] [2] [3] [4] [5] [6] In the present study we investigate whether preoperative functional imaging studies using FDG-PET and MEG enable prediction of postoperative seizure outcomes. The subjects of the study comprised 12 normal healthy volunteers and 36 patients with drug-resistant medial temporal lobe epilepsy who had surgery at Osaka City University Hospital, Japan, from December 2000 to March 2003; each subject underwent FDG-PET and MEG on the point aimed at the thalamus and its related cerebral neural activity.
Patients and methods
Careful preoperative evaluation was conducted in all patients to characterize the epileptic condition according to methodology described previously. 2 Briefly, all patients underwent multimodal evaluation that included magnetic resonance imaging (MRI), interictal and ictal video-EEG monitoring, FDG-PET, and MEG.
Patient population
Thirty-six consecutive patients (male, n = 16; female, n = 20; age range, 12-58 years; mean age, 37.2 years) with a medical history of intractable temporal lobe epilepsy were enrolled in the present study (Table 1) . Patients with any other structural lesions such as tumors, vascular malformations, cerebral contusions, cortical anomalies in the thalamus or sensorimotor cortex, or with symptoms related to cervical spondylosis were excluded from the study. The duration of seizure history ranged from 4 to 49 years, with mean duration of 25.1 years. All 36 patients subsequently underwent anterior temporal lobectomy with amygdalo-hippocampectomy or selective amygdalo-hippocampectomy with/without multiple subpial transection (MST) [12] [13] [14] after comprehensive preoperative evaluation. The present study was approved by the Ethics Committee of Osaka City University Hospital, and all patients gave their informed consent on admission to the study.
Magnetic resonance imaging
MRI was performed using a high-resolution 1.5 T scanner (SIGNA Horizon 1.5 Tesla, GE Yokogawa Medical Systems, Tokyo, Japan) for all patients. In all patients, multi-directional T1 and T2 images were acquired, and fluid-attenuated inversion recovery (FLAIR) images were also taken in planes parallel and perpendicular to the long axis of the hippocampus with 3 mm slice thickness to evaluate the amygdala and hippocampus.
F-fluorodeoxyglucose-positron emission tomography
Cerebral glucose metabolism was analyzed interictally using a PET scanner (HEADTOME IV, Shimadzu, Kyoto, Japan) with a spatial resolution of 4.5 mm (full width half maximum) and a slice thickness of 6.5 mm (14 slices). Scans were performed under Positive AI indicates low glucose metabolism on the ipsilateral thalamus of the epileptic temporal lobe, whereas negative AI indicates low metabolism on the contralateral thalamus.
Magnetoencephalography
All MEG measurements were performed in a magnetically shielded room at Osaka City University Hospital using a 160-channel whole-head type magnetoencephalographic system (MEG vision PQ1160C, Yokogawa Electric Corporation, Kanazawa, Japan) with a magnetic field resolution of 4 fT/Hz 1/2 in the white noise region. The sensing and reference coils each had a diameter of 15.5 mm, with a 50 mm base line and 23 mm separation between each pair of sensing coils. The sensing coils were firstorder gradiometers. 15 Somatosensory evoked magnetic fields (SEFs) were obtained by applying electrical stimuli in 0.1 ms pulses to the median nerve in the wrist with the cathode placed proximally. A forceps-like apparatus was used to fix the electrodes to the wrist and apply maximum stimulus to the median nerve. Four hundred stimuli were presented at a rate of 2 Hz, with responses passing through a 3-500 Hz bandpass filter. The sampling rate was 2000 Hz. The stimulation intensity was set at 1.5 times the threshold of a thenar muscle twitch, where the intensity of the dipole moment is saturated. The first main component of the SEF, with a latency of approximately 20 ms, is referred to as N20m and corresponds to N20 of the somatosensory evoked potentials (SSEPs). MRI was performed on all subjects. The MEG coordinates were transferred to the MRI coordinate system and localized using skin markers and coils. Single equivalent source dipole locations were estimated using the least-squares method with a spherically symmetrical head model. Dipoles with a goodness of fit (GOF) of at least 95% were used to determine dipole intensity (Fig. 2) . Equivalent current dipole intensity (ECDI) of N20m was measured twice in each hemisphere and the final intensity was determined as a mean. The asymmetry index (AI%) of ECDI (SEF-AI) was calculated using the following formula: AI = (Contra À Ipsi) Â 100/[(Contra + Ipsi)/2]. Positive AI indicates low neural activity in the ipsilateral cerebral hemisphere of the epileptic temporal lobe, whereas negative AI indicates low neural activity in the contralateral hemisphere.
Normal control
The normal absolute value of tCMRgluc and ECDI was determined in 12 healthy volunteers for each modality. The asymmetry indices (AI%) of tCMRGluc (PET-AI) and ECDI (SEF-AI) were calculated using the following formula: AI = (right À left) Â 100/[(right + left)/2]. All volunteers were free of any neurological or psychological disease, and were not taking any anti-epileptic drugs. Informed consent was obtained from each volunteer after the purpose and procedures of the present study had been explained.
Seizure outcome after epilepsy surgery
Postoperative seizure outcome was assessed at least 24 months after surgery (range, 24-63 months; mean, 39.4 months). Seizure outcomes were classified according to the classification proposed by the International League Against Epilepsy (ILAE) 16 : Class 1, completely seizure-free; Class 2, aura alone with no seizure; Class 3, one to three seizure days/year; Class 4, 50% reduction in baseline number of seizure days; Class 5, <50% reduction in baseline number of seizure days and Class 6, >100% increase in baseline number of seizure days.
Statistical analysis
The differences in PET-AI and SEF-AI between the patients and normal controls were analyzed using the unpaired t-test. The correlation between PET-AI and SEF-AI was analyzed using Pearson's correlation coefficient. Non-parametric analysis with Mann-Whitney's U-test was used to compare the postoperative seizure outcomes of the two independent patient groups. A statistically significant difference was defined as p < 0.05. All data were expressed as mean AE standard deviation.
Results

Comparison of PET-AI and SEF-AI between patients and normal controls
Quantitative analysis of PET-AI and SEF-AI in normal healthy volunteers revealed that the mean values were À0.4 AE 3.0% and 0.8 AE 9.7%, respectively. The cut-off level for the normal range was determined as the standard deviation; jPET-AIj > 3.0 and jSEFAIj > 9.7 were expressed as significant asymmetry of PET-AI and SEF-AI. Of the 36 patients with temporal lobe epilepsy, 21 patients (58.3%) and 29 patients (81%) were out of the normal range for PET-AI and SEF-AI, respectively (Table 2) . Mean PET-AI in the patients was 5.4 AE 5.2%, which was significantly different to the normal controls (p < 0.05), whereas mean SEF-AI was 25.2 AE 20.6% (not significantly different). PET-AI was positive (indicative for epileptic focus) in 29 of 36 patients (80.6%), and negative in 7 patients (19.4%). SEF-AI was positive in 17 of 36 patients (47.2%), and negative in 19 patients (52.8%) ( Table 2) . No significant correlation was noted between PET-AI and SEF-AI in patients (r = 0.43) (Fig. 3) .
Clinical impact of PET-AI and SEF-AI on surgical outcome
Patients were classified into two independent groups based on PET-AI and SEF-AI: Group 1 and Group 2. In Group 1 (concordant asymmetry group), both PET-AI and SEF-AI demonstrated more than the negative value of the standard deviation (PET-AI > À3.0 and SEF-AI > À9.7), which was indicative for ipsilateral epileptic focus; in Group 2 (discordant or paradoxical asymmetry group), either PET-AI or SEF-AI showed less than the negative value of the standard deviation (PET-AI < À3.0 and SEF-AI < À9.7), being indicative for contralateral epileptic focus (Fig. 3) 1-3 ), compared to 6 (40%) of the 15 patients in Group 2. Regarding postoperative seizure outcome, patients in Group 1 had significantly better outcomes compared to patients in Group 2 (p < 0.01) (Fig. 4) .
Discussion
In the present study, careful preoperative analysis using FDG-PET and MEG was conducted to predict postoperative seizure outcome in 36 patients with drug-resistant medial temporal lobe epilepsy. Although no significant correlation between PET-AI and SEF-AI was noted (r = 0.43), concordant asymmetry in both PET-AI and SEF-AI was significantly associated with better seizure outcome than discordant or paradoxical asymmetry of both factors (p < 0.01). Better understanding of diversity and complexity of temporal lobe epilepsy may enable us to formulate goals for surgical treatment. PET-AI: asymmetry index of thalamic glucose metabolism, SEF-AI: asymmetry index of somatosensory-evoked magnetic fields, Group 1: concordant asymmetry (AI with FDG-PET and MEG do not show the contralateral side of focus), Group 2: discordant or paradoxical asymmetry (AI with either FDG-PET or MEG shows the contralateral side of focus), negative value of AI: AI shows the contralateral side of the focus, bold letters: significant AI.
Extratemporal glucose metabolism in patients with temporal lobe epilepsy has been well studied using FDG-PET; the existence of thalamic glucose hypometabolism is considered to be associated with the activity or progression of temporal lobe epilepsy. 4, 6, [17] [18] [19] [20] [21] It is reported that thalamic glucose hypometabolism is well correlated with the side of epileptogenic focus, 22, 23 as PET-AI revealed the side of focus with statistical significance in the present study. It has been supposed that thalamic glucose hypometabolism in temporal lobe epilepsy is attributable to corticothalamic diaschisis. Extensive reciprocal connections between the thalamus, hippocampal formation, amygdala, and entorhinal cortex may play a role in a secondary change in thalamic glucose hypometabolism. 6, [20] [21] [22] [23] However, the preoperative thalamic glucose hypometabolism did not appear to be correlated with the postoperative seizure outcome in temporal lobe epilepsy. 24 This report implicates the diversity and complexity of metabolism alternations associated with the epileptogenesis in temporal lobe epilepsy. Neuromagnetic recordings in temporal lobe epilepsy have been studied in localizing the epileptogenic focuses. 2, [5] [6] [7] [8] [9] [25] [26] [27] In our previous report, the pattern of equivalent current dipole distribution was seen to be non-uniform regardless of the typical symptomatology of temporal lobe epilepsy; this suggests a diverse and complex mechanism of interictal epileptic phenomena in temporal lobe epilepsy. 2 In the present study, SEF, first reported by Brenner et al. in 1978, 28 was measured in patients with medically intractable temporal lobe epilepsy. The ECD of the first main component of SEF, having a latency of approximately 20 ms, is estimated as area 3b of the primary somatosensory cortex (SI) 29, 30 and its absolute magnitude represents the cortical or subcortical neural activity [31] [32] [33] [34] [35] [36] [37] ; it may also have a potential to detect the neural activity of thalamo-cortical neural pathway including the somatosensory cortex. [36] [37] [38] SEF-AI did not show the side of epileptogenic focus with statistical significance in the present study. This result suggests the diversity and complexity of neural activity in temporal lobe epilepsy and implies the diffuse focuses over the bilateral cerebral hemispheres. Although the measurement of SEF could be useful to estimate the thalamocortical function, it may not be valid in some patients with diffuse focuses. Although no significant relation was noted between PET-AI and SEF-AI, the patients in Group 1 (PET-AI and SEF-AI concordant asymmetry group) were revealed to have a significantly better outcome compared to the patients in Group 2 (PET-AI and SEF-AI discordant or paradoxical asymmetry group) (p < 0.01). What is the difference between Groups 1 and 2? It is reported that the focus in temporal lobe epilepsy may progress from localized to diffuse, 39 and that postoperative seizure outcome is improved in localized epileptic focus compared to diffuse focus [3] [4] [5] [6] [7] [8] [9] [10] [11] ; however, the mechanism of epileptic focus progression and diffusion over time remains unresolved. Morrell 40 proposed the clinical concept of secondary epileptogenesis which implies that an actively discharging epileptogenic region (primary focus), having massive neuronal connections with some other site, may gradually ''induce'' similar paroxysmal behavior in the cellular elements of the otherwise normal network (secondary focus). Not only the thalamolimbic neural circuits but also the cerebral hemisphere, which includes the sensory cortical area, is a part of the neural network of the epileptic brain and possibly represents a secondary focus in temporal lobe epilepsy. 41, 42 Furthermore, transcallosal connection may have a significant association with epileptogenesis in the contralateral cerebrum. 43, 44 Considering the progression of epileptogenesis in the present study, we speculate that patients in Group 1 may have a localized epileptic focus, whereas patients in Group 2 may have a diffuse epileptic focus.
The results of the present study, along with several previously mentioned studies, support the clinical concept that temporal lobe epilepsy may be a progressive and diffuse disease, and that progression of epileptogenesis in the brain may affect the postoperative seizure outcome, which is better for a localized epileptic focus than a diffuse focus. Temporal lobe epilepsy is thought to be a diffuse network disease. Surgical treatment may play a role in removing the neural circuit responsible for secondary epileptogenesis as well as resecting the primary epileptic focus; this may be the reason that some patients with a diffuse epileptic focus (Group 2) had good seizure outcome following surgery. Full understanding requires careful investigation of the progression of epileptogenesis. 
Conclusions
The results in the present study suggest that thalamic glucose hypometabolism has a significant relation with the epileptogenic focus of temporal lobe epilepsy, and is associated with the diverse and complex involvement of thalamo-cortical neural pathway. Although prediction of postoperative seizure outcome is not straightforward, quantitative analysis of thalamic glucose metabolism along with equivalent current dipole intensity of somatosensory-evoked magnetic fields may be of use in characterizing the preoperative epileptogenic condition and postoperative seizure outcome. A constellation of developmental brain abnormalities and environmental factors that together produce epilepsy need to be further explored.
